BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, January 18, 2026
See today's BioWorld Asia
Home
» Genor, Biocnd moving Humira biosimilar into clinical testing
To read the full story,
subscribe
or
sign in
.
Genor, Biocnd moving Humira biosimilar into clinical testing
Aug. 20, 2014
By
Cornelia Zou
HONG KONG – A Chinese biopharma has received approval from South Korean regulators to conduct local clinical trials on its biosimilar drug.
BioWorld Asia
